Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Repros receives guidance from FDA on Androxal in secondary hypogonadism

Jan. 29, 2010

Palatin Technologies claims MCR ligands for the treatment of sexual dysfunction

Jan. 29, 2010

Studies with tropisetron indicate that 5-HT3R is an antiobesity target

Jan. 29, 2010

Palatin Technologies and AstraZeneca disclose MC4 receptor agonists for treatment of obesity

Jan. 28, 2010

Efficacy and treatment satisfaction of Technosphere Insulin System reported by patients

Jan. 28, 2010

Acrux submits NDA to FDA for Axiron in hypogonadism

Jan. 28, 2010

JCR and Dainippon Sumitomo to terminate comarketing agreement for Growject

Jan. 28, 2010

Dainippon Sumitomo's Metgluco granted Japanese manufacturing and marketing approval

Jan. 28, 2010

FDA reschedules review of NDA for Theratechnologies' tesamorelin

Jan. 27, 2010

FDA approves Novo Nordisk's Victoza for certain adults with type 2 diabetes

Jan. 27, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...